sultopride - Compound Summary (CID 2159) Also known as: amisulpride, Solian, Aminosultopride, Deniban, 71675-85-9, Amisulpiride, Amisulprida, Amisulpridum, Socian, Amisulpridum [INN-Latin] Molecular Formula: C 17H 27N 3O 4S Molecular Weight: 369.47898 InChIKey: NTJOBXMMWNYJFB-UHFFFAOYSA-N Amisulpride (trade name Solian) is an antipsychotic drug sold by Sanofi-Aventis. It is not approved for use in the United States, but is approved for use in Europe and Australia for the treatment of psychoses and schizophrenia. Additionally, it is approved in Italy for the treatment of dysthymia (under the brand name Deniban). Amisulpride is a selective dopamine antagonist. From: DrugBank |
| | |
Identification Related Records Pharmacology Biomedical Effects and Toxicity Literature Patents Biomolecular Interactions and Pathways Biological Test Results Classification Chemical and Physical Properties |